Latest filings (excl ownership)
S-1
IPO registration
3 Jun 24
DEF 14A
Definitive proxy
31 May 24
8-K
Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
22 May 24
8-K
Alzamend Neuro, Inc. Corporate Presentation May 2024
15 May 24
8-K
Financial Statements and Exhibits
13 May 24
PRE 14A
Preliminary proxy
10 May 24
8-K/A
Entry into a Material Definitive Agreement
10 May 24
424B5
Prospectus supplement for primary offering
10 May 24
8-K
Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
9 May 24
8-K
Changes in Registrant's Certifying Accountant
9 May 24
424B5
Prospectus supplement for primary offering
7 May 24
8-K
Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
7 May 24
DEFA14A
Additional proxy soliciting materials
1 May 24
8-K
Submission of Matters to a Vote of Security Holders
1 May 24
8-K
Entry into a Material Definitive Agreement
30 Apr 24
8-K
Entry into a Material Definitive Agreement
29 Mar 24
10-Q
2024 Q3
Quarterly report
25 Mar 24
DEF 14A
Definitive proxy
25 Mar 24
8-K
Entry into a Material Definitive Agreement
22 Mar 24
NT 10-Q
Notice of late quarterly filing
18 Mar 24
PRE 14A
Preliminary proxy
13 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
7 Mar 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
10-Q
2024 Q2
Quarterly report
15 Dec 23
8-K
Regulation FD Disclosure
16 Nov 23
8-K
Alzamend Neuro Announces Reverse Stock Split
30 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Sep 23
8-K
Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement
22 Sep 23
10-Q
2024 Q1
Quarterly report
13 Sep 23
424B5
Prospectus supplement for primary offering
8 Sep 23
8-K
Entry into a Material Definitive Agreement
8 Sep 23
DEFA14A
Additional proxy soliciting materials
1 Sep 23
DEF 14A
Definitive proxy
24 Aug 23
8-K
Other Events
16 Aug 23
EFFECT
Notice of effectiveness
11 Aug 23
PRE 14A
Preliminary proxy
10 Aug 23
CORRESP
Correspondence with SEC
8 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Aug 23
Latest ownership filings
5
Lynne Fahey McGrath
16 May 24
4
MILTON C AULT III
23 Apr 24
4
MILTON C AULT III
3 Apr 24
4
MILTON C AULT III
1 Apr 24
4
MILTON C AULT III
28 Mar 24
SC 13D/A
AULT MILTON C III
2 Feb 24
4
MILTON C AULT III
2 Feb 24
SC 13D/A
AULT MILTON C III
25 Jan 24
4
MILTON C AULT III
25 Jan 24
4
MILTON C AULT III
9 Jan 24
4
MILTON C AULT III
27 Dec 23
4
David J Katzoff
26 Sep 23
4
MILTON C AULT III
26 May 23
4
Stephan Jackman
2 May 23
4
Lynne Fahey McGrath
23 Mar 23
4
MILTON C AULT III
20 Mar 23
4
William B. Horne
28 Feb 23
4
MILTON C AULT III
17 Feb 23
4
MILTON C AULT III
29 Dec 22
4
MILTON C AULT III
23 Dec 22
4
MILTON C AULT III
20 Dec 22
4
David J Katzoff
30 Nov 22
4
William B. Horne
30 Nov 22
4
KENNETH S CRAGUN
30 Nov 22
4
Stephan Jackman
30 Nov 22
4
MILTON C AULT III
21 Nov 22
4
MILTON C AULT III
15 Nov 22
SC 13D/A
AULT MILTON C III
15 Nov 22
4
MILTON C AULT III
3 Nov 22
4
MILTON C AULT III
1 Nov 22
4
MILTON C AULT III
14 Oct 22
4
MILTON C AULT III
7 Oct 22
4
MILTON C AULT III
30 Sep 22
4
MILTON C AULT III
26 Sep 22
4
Stephan Jackman
20 Sep 22
4
David J Katzoff
14 Sep 22
4
MILTON C AULT III
29 Aug 22
4
MILTON C AULT III
26 Aug 22
4
MILTON C AULT III
23 Aug 22
4
MILTON C AULT III
18 Aug 22